欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/0517/001
药品名称
Marpace
活性成分
hydrochlorothiazide 12.5 MG
ramipril 2.5 MG
剂型
Tablet
上市许可持有人
Teva B.V. 2031 GA Swensweg 5 Haarlem Netherlands (NL)
参考成员国 - 产品名称
Denmark (DK)
互认成员国 - 产品名称
许可日期
2003/11/14
最近更新日期
2019/11/04
药物ATC编码
C09BA05 ramipril and diuretics
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Article 4.8(a)(iii), first paragraph
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Labelling
|
Ramipril_HCT_DK_H_0516_0517_0519_001_002_OuP_08_03_19
Date of last change:2024/09/06
Final PL
|
Ramipril_HCT_DK_H_0516_0517_0519_001_002_PIL_08_03_19
Date of last change:2024/09/06
Final SPC
|
Ramipril_HCT_DK_H_0516_0517_0519_001_002_SmPC_08_03_19
Date of last change:2024/09/06
Final Product Information
|
Ramipril_HCT_PIL_clean
Date of last change:2024/09/06
Final Product Information
|
Ramipril_HCT_SmPC_clean
Date of last change:2024/09/06
市场状态
Withdrawn(注:已撤市)
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase